XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.25.2

Intangible Assets (Details) |  |  |  |  | 6 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | ---
Dec. 01, 2023 USD ($) | Mar. 05, 2023 USD ($) | Mar. 05, 2023 EUR (€) | Dec. 15, 2022 EUR (€) | Sep. 12, 2022 USD ($) | Jun. 30, 2025 USD ($) | Dec. 31, 2024 USD ($)
Intangible Assets [Line Items] |  |  |  |  |  |  |
Term fee |  | $ 56,325 | € 50,000 |  |  |  |
Signing the agreement |  | (112,650) | 100,000 |  |  |  |
Payment of license |  | $ 1,126,500 | € 1,000,000 | € 10,000 |  |  |
Royalty percentage |  | 2.00% | 2.00% | 3.00% |  |  |
Amount owed under agreement |  |  |  |  |  | $ 0 | $ 0
Licensing Agreements [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount |  |  |  |  |  | 736,983 | 736,983
Non Exclusive License Agreement [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount |  | $ 179,821 |  |  |  |  |
Various Generic Drugs [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount |  |  |  |  |  | 736,983 |
Four Generic Drugs (Encore) [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount |  |  |  |  | $ 1,308,270 |  |
Four Generic Drugs (Encore) [Member] | Licensing Agreements [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount |  |  |  |  |  | 1,308,270 | 1,308,270
Needleless Syringe License [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount | $ 26,060 |  |  |  |  |  |
Royalty fees |  |  |  |  |  | 26,060 | 26,060
Patents [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount |  |  |  |  |  | 48,420 |
Patent cost |  |  |  |  |  | 48,420 | 48,420
Non Exclusive License Agreement [Member] |  |  |  |  |  |  |
Intangible Assets [Line Items] |  |  |  |  |  |  |
Purchase amount |  |  |  |  |  | $ 179,821 | $ 179,821

X
- Definition The amount owed under license agreement. + References No definition available. + Details
Name: | klto_LicenseAgreementOwed
Namespace Prefix: | klto_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represent the amount of payment of signing the agreement. + References No definition available. + Details
Name: | klto_PaymentOfSigningTheAgreement
Namespace Prefix: | klto_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalty percentage. + References No definition available. + Details
Name: | klto_RoyaltyPercentage
Namespace Prefix: | klto_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of fee income including, but not limited to, managerial assistance, servicing of investment, and origination and commitment fees. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(1)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 + Details
Name: | us-gaap_FeeIncome
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 38 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 38 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 38 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 38 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 38 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 38 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 18: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31 Reference 19: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 29 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29 Reference 20: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 29 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29 Reference 21: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20 Reference 22: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20 Reference 23: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14 Reference 24: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14 Reference 25: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14 Reference 26: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14 Reference 27: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14 Reference 28: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 55 -Paragraph 40 -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1 Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3 Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 926 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other. + References No definition available. + Details
Name: | us-gaap_OtherIntangibleAssetsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash received from licensees for license fees during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_RoyaltyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=klto_NonExclusiveLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=klto_VariousGenericDrugsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=klto_FourGenericDrugsEncoreMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=klto_NeedlelessSyringeLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=klto_NonExclusiveLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |